FDA Inspection
ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbHABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH – FDA Inspection, Sep 30, 2021
Record Details
This FDA Inspection record concerns ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH, with an inspection on September 30, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 30, 2021
- Product Type
- Drugs
View Company Profile
ID · a40c778e-356c-4308-bb02-bf0a6687a11c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1234443
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 17, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 30, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH
- FDA Inspection 1202871 - 2023-03-17
- FDA Inspection 1035733 - 2017-09-15
- FDA Inspection 926013 - 2015-04-30
- FDA Inspection 793984 - 2012-07-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.